SCHEMBL30320387

SCHEMBL30320387

O=C1CCn2ncc([N+](=O)[O-])c2N1

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 8/20 0.36
CYP11B1 P15538 7/20 0.36
CRBN Q96SW2 4/20 0.33
DDB1 Q16531 3/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2523197 0.76 CYP1A2 (0.39) LMNA
SCHEMBL27199355 0.66 CYP1A2 (0.39) LMNA
SCHEMBL8795481 0.64 ALDH1A1 (0.35) LMNA
SCHEMBL31569009 0.64 MAPT (0.36) LMNA
SCHEMBL20400203 0.62 NLRP3 (0.38) LMNA
SCHEMBL18215091 0.62 MAPT (0.36)
SCHEMBL16469649 0.62 VCAM1 (0.36) LMNA
SCHEMBL2518380 0.62 LMNA (0.39) LMNA
SCHEMBL16470062 0.62 LRRK2 (0.40)
SCHEMBL30908216 0.61 MPO (0.37) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161494-A1 NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS KSQ Therapeutics, Inc. (US) 2023-04-12 EP disclosed